Literature DB >> 13143098

Acquired haemophilia-like disease; report of a case with studies on the mode of action of the circulating anticoagulant.

R M HARDISTY.   

Abstract

Entities:  

Keywords:  HEMORRHAGE; HEMORRHAGIC DIATHESIS; INTESTINES/hemorrhage; RHEUMATIC HEART DISEASE/complications

Mesh:

Substances:

Year:  1954        PMID: 13143098      PMCID: PMC1023692          DOI: 10.1136/jcp.7.1.26

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  3 in total

1.  Haemophilia-like syndrome from anticoagulants affecting the production of thromboplastin.

Authors:  I S COLLINS; D G FERRIMAN
Journal:  Lancet       Date:  1952-10-11       Impact factor: 79.321

2.  The formation of thromboplastin in human blood.

Authors:  R BIGGS; A S DOUGLAS; R G MACFARLANE
Journal:  J Physiol       Date:  1953-01       Impact factor: 5.182

3.  Refractoriness in hemophilia to coagulation-promoting agents: whole blood and plasma derivatives.

Authors:  W B FROMMEYER; R D EPSTEIN; F H L TAYLOR
Journal:  Blood       Date:  1950-05       Impact factor: 22.113

  3 in total
  6 in total

1.  A CIRCULATING ANTICOAGULANT INHIBITING ANTIHAEMOPHILIC GLOBULIN.

Authors:  P H PINKERTON; J H DAGG; F TAYLOR
Journal:  J Clin Pathol       Date:  1965-05       Impact factor: 3.411

2.  Treatment with cortisone of haemorrhagic disease due to a circulating anticoagulant.

Authors:  W M HENDERSON
Journal:  Br Med J       Date:  1959-03-21

3.  Antithromboplastin: the degeneration of intrinsic thromboplastin in normal serum.

Authors:  C G BERRY
Journal:  J Clin Pathol       Date:  1958-01       Impact factor: 3.411

4.  [Immune-antibody hemophilia A].

Authors:  A WINDORFER; H E SCHULTZE; G SCHWICK
Journal:  Blut       Date:  1956-07

5.  [Protamine sulfate and toluidine blue in hemostasis of uterine hemorrhages].

Authors:  F K BELLER; M NAEGELE
Journal:  Arch Gynakol       Date:  1956

6.  A circulating anticoagulant occurring after temporal arteritis and controlled by corticosteroid therapy.

Authors:  A G WHITFIELD; M J MEYNELL; B M FESSEY; W A HUDSON
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.